Biotek-snakken — April 2020
-
God morgen.

-
God morgen.

-
Test
-
Healthcare har genvundet hele årets tab: https://www.proinvestor.com/investornyt/659641/stoxx-sektorer-healtcare-tilbage-ved-arsstart-banker-fortsat-i-bund
-
Nogle her der har Urogen Pharma (URGN), ser spændende ud:
https://blog.tipranks.com/with-fda-approvals-in-hand-these-2-biotech-stocks-are-on-wall-streets-radar/?utm_source=tipranks.com&utm_medium=newsletters_story&utm_campaign=story_wed_22.04.2020_ult -
Spændende hvorledes der tages mod data fra Sutros STRO-002 - altid svært at vurdere disse preliminære data. Umiddelbart efter eet hurtigt kig vurdere jeg at effekten er på niveau med Mirvetuximab og bivirkningsprofilen bedre. Glæder mig til at se video og høre CC.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

